Cashu | RGNX | News

HomeWatchlistNewsSignalsPicks

DJI

-0.13%

SPX

+0.11%

IXIC

+0.17%

FTSE

+0.69%

N225

+1.26%

AXJO

-1.06%

⌘K

HomeWatchlistNewsSignals

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Stocks

Health Care

rgnx

Regenxbio

NASDAQ: RGNX

-0.10 (-1.16%)

8.53

USD

At close at Apr 03, 20:40 UTC

Latest Regenxbio News

RGNX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit

Feature Image for interests on Healthcare, P. A., Stock, The Rosen Law Firm from prnewswire.com

REGENXBIO, Inc. Class Action Reminder - Robbins LLP Encourages RGNX Stockholders to Contact the Firm for Information About Their Rights

Feature Image for interests on Healthcare, Robbins Llp, Stock from prnewswire.com

about 2 hours ago

STEPHEN PAKOLA OVERSAW RGX-111 SAFETY CLAIMS THAT COST RGNX INVESTORS MILLIONS: LEVI & KORSINSKY, LLP

Feature Image for interests on Consumer Defensive, Healthcare, Stock, Unknown Sector from prnewswire.com

RGNX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit

Feature Image for interests on Banking & Financial Services, Healthcare, Stock from prnewswire.com

REGENXBIO Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RGNX

RGNX Investors Have Opportunity to Lead REGENXBIO Inc. Securities Fraud Lawsuit with the Schall Law Firm

Feature Image for interests on Healthcare, Stock from prnewswire.com

SUEWALLST, LLP: INSTITUTIONAL RGNX HOLDERS FACE PORTFOLIO LOSSES FROM GENE THERAPY FRAUD

Feature Image for interests on Healthcare, Stock, Unknown Sector from prnewswire.com

FDA Clears Denali Therapeutics Drug As First Brain-Penetrating Biologic For Rare Disease

Feature Image for interests on Analyst Color, Biotech, Expert Ideas, Health Care from benzinga.com

STEPHEN PAKOLA OVERSAW RGX-111 SAFETY CLAIMS THAT COST RGNX INVESTORS MILLIONS: LEVI & KORSINSKY, LLP

Feature Image for interests on Consumer Defensive, Healthcare, Stock, Unknown Sector from prnewswire.com

RGNX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit

Feature Image for interests on Healthcare, Stock from prnewswire.com

Join our newsletter to keep up to date with us!

Latest Cashu News

Legal Action Against REGENXBIO's Dr. Pakola Highlights Gene Therapy Safety Concerns

about 13 hours ago

Regenxbio Faces Class Action Lawsuits Over Misleading Claims on RGX-111 Gene Therapy

Regenxbio Sued for Alleged Misleading Claims on Gene Therapy RGX-111 Safety and Efficacy